{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:18:48Z","timestamp":1778642328297,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shaanxi social development science and technology research project","award":["2021SF-138"],"award-info":[{"award-number":["2021SF-138"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-026-10180-5","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:16:42Z","timestamp":1775114202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The PRKN\/METTL3\/CLDN2 axis promotes colorectal cancer development through epigenetic mechanisms"],"prefix":"10.1007","volume":"42","author":[{"given":"Hongtao","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mincong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiulong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"9","key":"10180_CR1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2174\/18735592MTEx9NTk2y","volume":"22","author":"F Baidoun","year":"2021","unstructured":"Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT, et al. Colorectal cancer epidemiology: recent trends and impact on outcomes. Curr Drug Targets. 2021;22(9):998\u20131009.","journal-title":"Curr Drug Targets"},{"issue":"5","key":"10180_CR2","first-page":"279","volume":"21","author":"M Bai-xiang","year":"2024","unstructured":"Bai-xiang M, Yuan xiang L, Hua jian Z, Ningyuan Y, Jin-yong Z, Min C. Predicting and validating the mechanism of action of the enema formula in treating colorectal cancer by using network pharmacology, GEO, and TCGA databases. Curr Proteomics. 2024;21(5):279\u201392.","journal-title":"Curr Proteomics"},{"issue":"4","key":"10180_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","volume":"160","author":"H Chen","year":"2021","unstructured":"Chen H, Gao S, Liu W, Wong CC, Wu J, Wu J, et al. RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 axis and is a therapeutic target. Gastroenterology. 2021;160(4):1284\u20131300.e1216.","journal-title":"Gastroenterology"},{"issue":"4","key":"10180_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","volume":"163","author":"H Chen","year":"2022","unstructured":"Chen H, Pan Y, Zhou Q, Liang C, Wong CC, Zhou Y, et al. METTL3 inhibits antitumor immunity by targeting m(6)A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer. Gastroenterology. 2022;163(4):891\u2013907.","journal-title":"Gastroenterology"},{"issue":"6","key":"10180_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10863-024-10039-6","volume":"56","author":"G Chen","year":"2024","unstructured":"Chen G, Cong L, Gu C, Li P. PRKN-mediated the ubiquitination of IQGAP3 regulates cell growth, metastasis and ferroptosis in early-onset colorectal cancer. J Bioenerg Biomembr. 2024a;56(6):645\u201355.","journal-title":"J Bioenerg Biomembr"},{"issue":"13","key":"10180_CR6","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41388-024-02956-y","volume":"43","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zhou J, Wu Y, Chen F, Li J, Tao L, et al. METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability. Oncogene. 2024b;43(13):976\u201391.","journal-title":"Oncogene"},{"issue":"2","key":"10180_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28(2):591\u2013605.","journal-title":"Cell Death Differ"},{"issue":"10","key":"10180_CR8","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1111\/cas.15083","volume":"112","author":"J Cui","year":"2021","unstructured":"Cui J, Tian J, Wang W, He T, Li X, Gu C, et al. IGF2BP2 promotes the progression of colorectal cancer through a YAP-dependent mechanism. Cancer Sci. 2021;112(10):4087\u201399.","journal-title":"Cancer Sci"},{"key":"10180_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol. 2022;13:888713.","journal-title":"Front Immunol"},{"key":"10180_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020290","author":"I Hashimoto","year":"2022","unstructured":"Hashimoto I, Oshima T. Claudins and gastric cancer: an overview. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14020290.","journal-title":"Cancers"},{"issue":"1","key":"10180_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7150\/ijbs.72538","volume":"19","author":"X He","year":"2023","unstructured":"He X, Chen H, Zhong X, Wang Y, Hu Z, Huang H, et al. BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer. Int J Biol Sci. 2023;19(1):331\u201345.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10180_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, et al. Exosome-derived circCCAR1 promotes CD8\u2009+\u2009T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023;22(1):55.","journal-title":"Mol Cancer"},{"issue":"3","key":"10180_CR13","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1021\/acs.molpharmaceut.0c00961","volume":"18","author":"H Lan","year":"2021","unstructured":"Lan H, Liu Y, Liu J, Wang X, Guan Z, Du J, et al. Tumor-associated macrophages promote oxaliplatin resistance via METTL3-mediated m(6)A of TRAF5 and necroptosis in colorectal cancer. Mol Pharm. 2021;18(3):1026\u201337.","journal-title":"Mol Pharm"},{"issue":"1","key":"10180_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1038-7","volume":"18","author":"T Li","year":"2019","unstructured":"Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, et al. METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma. Mol Cancer. 2019;18(1):112.","journal-title":"Mol Cancer"},{"issue":"1","key":"10180_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00557-2","volume":"18","author":"Q Liu","year":"2020","unstructured":"Liu Q, Yang C, Wang S, Shi D, Wei C, Song J, et al. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression. Cell Commun Signal. 2020;18(1):51.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"10180_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04950-2","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, He H, Zhang F, Hu X, Bi F, Li K, et al. m6A methylated EphA2 and VEGFA through IGF2BP2\/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K\/AKT and ERK1\/2 signaling. Cell Death Dis. 2022;13(5):483.","journal-title":"Cell Death Dis"},{"issue":"1","key":"10180_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0115701646291510240212091951","volume":"21","author":"Z Nannan","year":"2024","unstructured":"Nannan Z, Junzhi L, Qiuping D, Chen L, Xinyu L, Peiyuan T, et al. Proteomic analysis of the molecular mechanisms of chlorpromazine inhibiting migration of oral squamous cell carcinoma. Curr Proteomics. 2024;21(1):2\u201313.","journal-title":"Curr Proteomics"},{"issue":"1","key":"10180_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03035-6","volume":"43","author":"P Ouyang","year":"2024","unstructured":"Ouyang P, Li K, Xu W, Chen C, Shi Y, Tian Y, et al. METTL3 recruiting M2-type immunosuppressed macrophages by targeting m6A-SNAIL-CXCL2 axis to promote colorectal cancer pulmonary metastasis. J Exp Clin Cancer Res. 2024;43(1):111.","journal-title":"J Exp Clin Cancer Res"},{"key":"10180_CR19","doi-asserted-by":"crossref","unstructured":"Pan J, Liu F, Xiao X, Xu R, Dai L, Zhu M, et al. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis. J Exp Clin Cancer Res CR. 2022;41(1):19.","DOI":"10.1186\/s13046-021-02227-8"},{"issue":"Pt 3","key":"10180_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2022.05.009","volume":"86","author":"D Ramesh-Kumar","year":"2022","unstructured":"Ramesh-Kumar D, Guil S. The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer. Semin Cancer Biol. 2022;86(Pt 3):18\u201331.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10180_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","volume":"83","author":"E Sendinc","year":"2023","unstructured":"Sendinc E, Shi Y. RNA m6A methylation across the transcriptome. Mol Cell. 2023;83(3):428\u201341.","journal-title":"Mol Cell"},{"key":"10180_CR22","doi-asserted-by":"crossref","unstructured":"Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X, et al. m(6)A-dependent glycolysis enhances colorectal cancer progression. Mol Cancer. 2020;19(1):72.","DOI":"10.1186\/s12943-020-01190-w"},{"issue":"2","key":"10180_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1515\/revneuro-2020-0083","volume":"32","author":"A Sturchio","year":"2021","unstructured":"Sturchio A, Dwivedi AK, Vizcarra JA, Chirra M, Keeling EG, Mata IF, et al. Genetic parkinsonisms and cancer: a systematic review and meta-analysis. Rev Neurosci. 2021;32(2):159\u201367.","journal-title":"Rev Neurosci"},{"issue":"8","key":"10180_CR24","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.lddd.2025.100138","volume":"22","author":"M Su","year":"2025","unstructured":"Su M, Chen W, Luo J, Li X, Ye D, Han D, et al. METTL14-induced N6-methyladenosine modification on TPX2 mRNA inhibits tumor progression in clear cell renal cell carcinoma. Lett Drug Des Discov. 2025;22(8):100138.","journal-title":"Lett Drug Des Discov"},{"key":"10180_CR25","doi-asserted-by":"crossref","unstructured":"Sulkshane P, Duek I, Ram J, Thakur A, Reis N, Ziv T, et al. Inhibition of proteasome reveals basal mitochondrial ubiquitination. J Proteomics. 2020;229:103949.","DOI":"10.1016\/j.jprot.2020.103949"},{"issue":"11","key":"10180_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06287-w","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun Y, Gong W, Zhang S. METTL3 promotes colorectal cancer progression through activating JAK1\/STAT3 signaling pathway. Cell Death Dis. 2023;14(11):765.","journal-title":"Cell Death Dis"},{"key":"10180_CR27","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","DOI":"10.3322\/caac.21660"},{"issue":"1","key":"10180_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02189-9","volume":"4","author":"S Tabari\u00e8s","year":"2021","unstructured":"Tabari\u00e8s S, Annis MG, Lazaris A, Petrillo SK, Huxham J, Abdellatif A, et al. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern. Commun Biol. 2021;4(1):657.","journal-title":"Commun Biol"},{"issue":"1","key":"10180_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15548627.2021.1888244","volume":"18","author":"P Tere\u0161ak","year":"2022","unstructured":"Tere\u0161ak P, Lapao A, Subic N, Boya P, Elazar Z, Simonsen A. Regulation of PRKN-independent mitophagy. Autophagy. 2022;18(1):24\u201339.","journal-title":"Autophagy"},{"issue":"2","key":"10180_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1158\/1541-7786.MCR-06-0071","volume":"5","author":"A Thakur","year":"2007","unstructured":"Thakur A, Rahman KW, Wu J, Bollig A, Biliran H, Lin X, et al. Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer. Mol Cancer Res. 2007;5(2):171\u201381.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10180_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11427-024-2897-y","volume":"69","author":"Y Tian","year":"2026","unstructured":"Tian Y, Peng J, Zhou J, Yang W, Peng Y, Li J, et al. N(6)-methyladenosine attenuates tumor-associated macrophages M2 polarization via suppressing the translation of Snail. Sci China Life Sci. 2026;69(1):119\u201335.","journal-title":"Sci China Life Sci"},{"issue":"12","key":"10180_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.667","volume":"11","author":"M Wei","year":"2021","unstructured":"Wei M, Zhang Y, Yang X, Ma P, Li Y, Wu Y, et al. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription. Clin Transl Med. 2021;11(12):e667.","journal-title":"Clin Transl Med"},{"issue":"21","key":"10180_CR33","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/s41388-024-03009-0","volume":"43","author":"Q Wu","year":"2024","unstructured":"Wu Q, Wang Z, Chen S, She X, Zhu S, Li P, et al. USP26 promotes colorectal cancer tumorigenesis by restraining PRKN-mediated mitophagy. Oncogene. 2024;43(21):1581\u201393.","journal-title":"Oncogene"},{"issue":"9","key":"10180_CR34","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82(9):1660\u20131677.e1610.","journal-title":"Mol Cell"},{"key":"10180_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114118","volume":"230","author":"P Xu","year":"2022","unstructured":"Xu P, Ge R. Roles and drug development of METTL3 (methyltransferase-like 3) in anti-tumor therapy. Eur J Med Chem. 2022;230:114118.","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10180_CR36","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1080\/15548627.2022.2164427","volume":"19","author":"C Yang","year":"2023","unstructured":"Yang C, Wang Z, Kang Y, Yi Q, Wang T, Bai Y, et al. Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3BP1 and autophagy-dependent elimination of stress granules. Autophagy. 2023;19(7):1934\u201351.","journal-title":"Autophagy"},{"key":"10180_CR37","doi-asserted-by":"crossref","unstructured":"Yao B, Zhang Q, Yang Z, An F, Nie H, Wang H, et al. CircEZH2\/miR-133b\/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m(6)A-modified CREB1 mRNA. Mol Cancer. 2022;21(1):140.","DOI":"10.1186\/s12943-022-01608-7"},{"issue":"1","key":"10180_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02305-9","volume":"10","author":"H Yuan","year":"2025","unstructured":"Yuan H, Li Q, Li L, Zhao G, Zhang J, Feng T, et al. DDX39B K63-linked ubiquitination mediated by TRIM28 promotes NSCLC metastasis by enhancing ECAD lysosomal degradation. Signal Transduct Target Ther. 2025;10(1):221.","journal-title":"Signal Transduct Target Ther"},{"issue":"23","key":"10180_CR39","doi-asserted-by":"publisher","first-page":"11370","DOI":"10.1073\/pnas.1816847116","volume":"116","author":"AS Zannas","year":"2019","unstructured":"Zannas AS, Jia M, Hafner K, Baumert J, Wiechmann T, Pape JC, et al. Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-\u03baB-driven inflammation and cardiovascular risk. Proc Natl Acad Sci U S A. 2019;116(23):11370\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10180_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020;13(1):117.","journal-title":"J Hematol Oncol"},{"key":"10180_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0662-4","volume":"18","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang H, Li Q, Li T. Cldn2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin\/ERK signaling pathway. Cancer Cell Int. 2018;18:160.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10180_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-021-01042-0","volume":"14","author":"S Zhao","year":"2021","unstructured":"Zhao S, Mi Y, Guan B, Zheng B, Wei P, Gu Y, et al. Correction to: tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. J Hematol Oncol. 2021;14(1):33.","journal-title":"J Hematol Oncol"},{"key":"10180_CR43","doi-asserted-by":"crossref","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res 2016;44(10):e91.","DOI":"10.1093\/nar\/gkw104"},{"key":"10180_CR44","doi-asserted-by":"crossref","unstructured":"Zhu X, Liang R, Lan T, Ding D, Huang S, Shao J, Zheng Z, Chen T, Huang Y, Liu J et al. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer. J Immun Cancer 2022;10(9).","DOI":"10.1136\/jitc-2021-004219"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10180-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10180-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10180-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:05:21Z","timestamp":1778641521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10180-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10180"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10180-5","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of Second Affiliated Hospital of Xi\u2019an Jiaotong University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"64"}}